China Kexing Biotech stated on October 9 that according to a research report by the Chilean Ministry of Health, people who have completed two doses of Sinovac's new coronavirus pneumonia (COVID-19) vaccine received the third booster dose. The protective power brought will be increased to more than 80%.
Chile's new crown pneumonia epidemic: The picture shows a girl in Concon, Chile being vaccinated with the new crown vaccination on September 27.
(Reuters)
The Chilean Ministry of Health published a related study on October 7. According to Xinhua News Agency, the Chilean Ministry of Health targeted people who had completed two doses of Coxing Vaccine, were over 16 years old, and had not been infected with COVID-19 before participating in the study.
The research team vaccinated these participants with Kexing vaccine, Pfizer vaccine, and AstraZeneca vaccine as the third booster, and then observed the vaccine 14 days later to prevent infection with symptomatic new coronary pneumonia and prevent the disease from becoming serious To be efficient in hospital admissions.
The results of the study showed that the effective rate of two doses of Kexing vaccine in preventing infection with symptomatic new coronary pneumonia was 56%. After vaccinating Kexing vaccine, Pfizer vaccine, and AstraZeneca vaccine as the third booster, the effective rate increased to 80.2%, 90% and 93%.
The results also showed that the effective rate of two doses of Kexing vaccine in preventing the condition from becoming severe enough to be hospitalized was 84%. After the third booster of Kexing vaccine, Pfizer vaccine, and AstraZeneca vaccine, the effective rates were different. Increased to 88%, 87% and 96.3%.
The Chilean Ministry of Health stated that the results of the study support the government to vaccinate all those who have completed the third dose.
U.S. media: Forbidex has a long-lasting effect and relatively low side effects. South American transgender rush to reduce the use of Chinese vaccines. The United States relaxes restrictions on vaccination. WHO approved 6 vaccines. New Zealand will require foreign immigrants to complete vaccination. 22 vaccines are approved. Including Coxing New Crown Vaccine | Malaysia Approves 12-17 Years Old Vaccination Coxing Argentina to Give Children National Drugs